T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 1, 2006, Pages 119-129

  Torres, M J ^a   Mayorga, C ^a   Fernandez T D ^a   Cornejo Garcia J A ^a   Antunez C ^a   Valenzuela, M ^a   Del Prado, M F ^a   Rodriguez Pena, R ^a   Blanca, M ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Activation markers; CLA; Drug reactions; IgE; Peripheral blood; Severity; Skin; T cells

Indexed keywords

ACECLOFENAC; ALLOPURINOL; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAMAZEPINE; CEFACLOR; CEFALEXIN; CEFUROXIME; DIPYRONE; EBASTINE; HLA DR ANTIGEN; HOMING RECEPTOR; IBUPROFEN; METRONIDAZOLE; NIMODIPINE; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; TETRAZEPAM;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; SEROLOGY; SKIN; STATISTICAL ANALYSIS; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; RECEPTORS, LYMPHOCYTE HOMING; SKIN; SKIN TESTS; T-LYMPHOCYTES; TIME FACTORS;

EID: 33646265033     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Demoly P. and J. Bousquet. 2001. Epidemiology of drug allergy. Curr. Opin. Allergy Clin. Immunol. 1:305.
2. Thong B.Y., K. Leong, C. Tang and H. Chang. 2003. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann. Allergy Asthma Immunol. 90:342.
3. Levine B.B. 1966. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. N. Engl. J. Med. 275:1115.
4. Blanca M., M.J. Torres, C. Mayorga, E. Perez-Inestrosa, R. Suau, M.I. Montañez and C. Juarez. 2004. Immediate allergic reactions to betalactams: Facts and controversies. Curr. Opin. Allergy Clin. Immunol. 4:261.
5. Warrington R.J., F. Silviu-Dan and C. Magro. 1993. Accelerated cell-mediated immune reactions in penicillin allergy. J. Allergy Clin. Immunol. 92:626.
6. Posadas S.J., L. Leyva, M.J. Torres, J.L. Rodriguez, I. Bravo, M. Rosal, J. Fernandez, C. Juarez and M. Blanca. 2000. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J. Allergy Clin. Immunol. 106:769.
7. Brander C., D. Mauri-Hellweg, H.P. Rolli, M. Goldman and W.J. Pichler. 1995. Heterogeneus T cell response to beta-lactam-modified self structures in penicillin allergic individuals. J. Immunol. 155:2670.
8. Mauri-Helweg D., F. Bettens, D. Mauri, C. Brander, T. Hunziker and W.J. Pichler. 1995. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J. Immunol. 155:462.
9. Leyva L., M.J. Torres, S. Posadas, M. Blanca, G. Besso, F. O'Valle, R.G. del Moral, L.F. Santamaria and Juarez C. 2000. Anticonvulsant-induced toxic epidermal necrolysis. Monitoring of the immunologic response. J. Allergy Clin. Immunol. 105:157.
10. Gonzalez F.J., M.J. Carvajal, V. del Pozo and M. Blanca. 1997. Erythema multiforme to phenobarbital: involvement of eosinophils and T cells expressing the skin homing receptor. J. Allergy Clin. Immunol. 100:135.
11. Hari Y., K. Frutig-Schnyder, M. Hurni, N. Yawalkar, M.P. Zanni, B. Schnyder, A. Kappeler, S. von Greyerz, L.R. Braathen and W.J. Pichler. 2001. T cell involvement in cutaneous drug eruptions. Clin. Exp. Allergy 31:1398.
12. Villada G., J.C. Roujeau, T. Clérici, I. Bourgalt and J. Revuz. 1992. Inmunopathology of toxic epidermal necrolysis, keratinocites, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch. Dermatol. 128:50.
13. Roujeau J.C., L. Dubertret, S. Moritz, H. Jouault, M. Heslan, J. Revuz and R. Touraine. 1985. Involvement of macrophages in the pathology of toxic epidermal necrolysis. Br. J. Dermatol. 113:425.
14. Friedmann P.S., I. Strickland, M. Pirmohamed and B.K. Park. 1994. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch. Dermatol. 130:598.
15. Nassif A., A. Bensussan, L. Boumsell, A. Deniaud, H. Moslehi, P. Wolkenstein, M. Bagot and J.C. Roujeau. 2004. Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells. J. Allergy Clin. Immunol. 114:1209.
16. Mayorga C., M.J. Torres, J.L. Corzo, E. Sanchez-Sabate, J. Alvarez, A. Vera, S. Posadas, A. Jurado and M. Blanca. 2003. Improvement of Toxic Epidermal Necrolysis after the Early Administration of a Single High Dose of Intravenous Immunoglobulin. Ann. Allergy Asthma Immunol. 91:86.
17. Roujeau J.C. and R.S. Stern. 1994. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331:1272.
18. Brockow K., A. Romano, M. Blanca, J. Ring, W. Pichler and P. Demoly. 2002. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57:45.
19. Aberer W., A. Bircher, A. Romano, M. Blanca, P. Campi, J. Fernandez, K. Brockow, W.J. Pichler, P. Demoly and European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. 2003. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 58:854.
20. Stevenson D.D., R.A. Simon and B.L. Zuraw. 2003. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In Allergy: principles and practice. N.F. Adkinson, J.W. Yunginger, W.W. Busse, B.S. Bochner, S.T. Holgate, F.E. Simons, ed. Middleton's. Vol. 2: Mosby, Inc, Philadelphia p. 1695.
21. N. Yawalkar, F. Egli, Y. Hari, H. Nievergelt, L.R. Braathen and W.J. Pichler. 2000. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin. Exp. Allergy 30:847.
22. Posadas S.J., A. Padial, M.J. Torres, C. Mayorga, L. Leyva, E. Sanchez, J. Alvarez, A. Romano, C. Juarez and M. Blanca. 2002. Delayed reactions to drugs show a Th1 profile and levels of perforin, granzyme B and Fas-L related to disease severity. J. Allergy Clin. Immunol. 109:155.
23. Descotes J. and G. Choquet-Kastylevsky. 2001. Gell and Coombs's classification: is it still valid? Toxicology 158:43.
24. Reddy M., E. Eirikis, C. Davis, H.M. Davis and U. Prabhakar. 2004. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J. Immunol. Methods 293:127.
25. Picker L.J., J.R. Treer, B. Ferguson-Darnell, P.A. Collins, P.R. Bergstresser and L.W. Terstappen. 1993. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J. Immunol. 150:1122.
26. Dworzak M.N., G. Froschl, D. Printz, C. Fleischer, U. Potschger and G. Fritsch. 1999. Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: signs of subset expansion and stimulation. J. Allergy Clin. Immunol. 103:901.
27. Blanca M., S. Posadas, M.J. Torres, L. Leyva, C. Mayorga, L. Gonzalez, C. Juarez, J. Fernandez and L.F. Santamaria. 2000. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with non-immediate cutaneous allergic drug reactions. Allergy 55:998.
28. Antunez C., M.J. Torres, C. Mayorga, J.A. Cornejo-Garcia, L.F. Santamaria-Babi and M. Blanca. 2004. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis. Clin. Exp. Allergy 34:559.
29. Torres M.J., J.L. Corzo, L. Leyva, C. Mayorga, F.J. Garcia-Martin, C. Antunez, S. Posadas, A. Jurado and M. Blanca. 2003. Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. Blood Cells Mol. Dis. 30:124.
30. Naisbitt D.J. 2004. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 194:179.
31. Friedmann P.S., M.S. Lee, A.C. Friedmann and R.C. Barnetson. 2003. Mechanisms in cutaneous drug hypersensitivity reactions. Clin. Exp. Allergy 33:861.
32. Nassif A., H. Moslehi, S. Le Gouvello, M. Bagot, L. Lyonnet, L. Michel, L. Boumsell, A. Bensussan and J.C. Roujeau. 2004. Evaluation of the potential role of cytokines in Toxic Epidermal Necrolysis. J. Invest. Dermatol. 123:850.
33. Naisbitt D.J., M. Britschgi, G. Wong, J. Farrell, J.P. Depta, D.W. Chadwick, W.J. Pichler, M. Pirmohamed and B.K. Park. 2003. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, cytokine profile of drug specific T cell clones. Mol. Pharmacol. 63:732.